|
|
|
Volumn 38, Issue 4, 2001, Pages 160-163
|
|
Human genome project and pharmacogenomics: Leading towards individualized medication
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN E4;
BETA 2 ADRENERGIC RECEPTOR;
CALCIUM CHANNEL BLOCKING AGENT;
CALCIUM ION;
CORTICOSTEROID;
CYTOCHROME P450;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DNA;
GENE PRODUCT;
INSULIN RECEPTOR;
ISONIAZID;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
TERFENADINE;
ALLELE;
ALZHEIMER DISEASE;
ASTHMA;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
DIAGNOSTIC TEST;
DNA MICROARRAY;
DRUG ACETYLATION;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG RESPONSE;
GENE;
GENETIC ANALYSIS;
GENETIC PREDISPOSITION;
GENOME;
GENOTYPE;
HUMAN;
HYPERTENSION;
IMMUNITY;
INDIVIDUALITY;
MEDICAL ETHICS;
MOLECULAR INTERACTION;
MULTIDRUG RESISTANCE;
PHARMACOGENOMICS;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
SHORT SURVEY;
SIDE EFFECT;
|
|
EID: 0034903987
PISSN: 0019462X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (4)
|
|
References (6)
|
